Alfentanil Injection
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Alfentanil Injection is a sterile solution of Alfentanil Hydrochloride in Water for Injection. It contains an amount of Alfentanil Hydrochloride equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of alfentanil (C21H32N6O3).
[Caution—Handle Alfentanil Injection with great care because it is a potent opioid analgesic.]
2 IDENTIFICATION
A. Thin-Layer Chromatographic Identification Test 〈201〉
Standard solution: 0.54 mg/mL of USP Alfentanil Hydrochloride RS
Sample solution: 0.5 mg/mL of alfentanil in water
2.1 Chromatographic system
Application volume: 200 µL
Developing solvent system: Chloroform, methanol, and formic acid (85:10:5)
Visualizing agent: Dragendorff's reagent
2.2 Analysis
Samples: Standard solution and Sample solution
Proceed as directed in the chapter.
Acceptance criteria: Meets the requirements
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 Procedure
Mobile phase: Acetonitrile and 0.01 M tetrabutylammonium hydrogen sulfate (14:86)
Standard solution: 0.54 mg/mL of USP Alfentanil Hydrochloride RS in saline TS
Sample solution: Equivalent to 0.50 mg/mL of alfentanil from a suitable volume of Injection in saline TS Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 235 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Flow rate: 2 mL/min
Injection volume: 25 µL
System suitability
Sample: Standard solution
Suitability requirements
Column eciency: NLT 5400 theoretical plates
Tailing factor: NMT 1.3
Relative standard deviation: NMT 1.0%
3.2 Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of alfentanil (C21H32N6O3 ) in the portion of Injection taken:
Result = (rU /rS ) × (CS /CU ) × (Mr1 /Mr2 ) × 100
rU = peak response from the Sample solution
rS = peak response from the Standard solution
CS = concentration of USP Alfentanil Hydrochloride RS in the Standard solution (mg/mL)
CU = nominal concentration of alfentanil in the Sample solution (mg/mL
Mr1 = molecular weight of alfentanil, 416.52
Mr2 = molecular weight of alfentanil hydrochloride, 452.98
Acceptance criteria: 90.0%–110.0%
4 IMPURITIES
4.1 Organic Impurities
Mobile phase: Acetonitrile and 0.01 M tetrabutylammonium hydrogen sulfate (14:86)
Standard solution: 0.54 mg/mL of USP Alfentanil Hydrochloride RS in saline TS
Sample solution: Equivalent to 0.50 mg/mL of alfentanil from a suitable volume of Injection in saline TS
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 235 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Flow rate: 2 mL/min
Injection volume: 25 µL
System suitability
Sample: Standard solution
Suitability requirements
Column eciency: NLT 5400 theoretical plates
Tailing factor: NMT 1.3
Relative standard deviation: NMT 1.0%
4.2 Analysis
Sample: Sample solution
Calculate the percentage of each impurity in the portion of Injection taken:
Result = (rU /rT ) × 100
rU = peak response of each impurity
rT = sum of all of the peaks
Acceptance criteria: The sum of all impurities is NMT 2.0%.
5 SPECIFIC TESTS
pH 〈791〉: 4.0–6.0
Particulate Matter in Injections 〈788〉: Meets the requirements for small-volume injections
Bacterial Endotoxins Test 〈85〉: NMT 10 USP Endotoxin Units/mL
Other Requirements: Meets the requirements in Injections and Implanted Drug Products 〈1〉
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, single-dose or multiple-dose containers, preferably of Type I glass, and store at controlled room temperature.
USP Reference Standards 〈11〉
USP Alfentanil Hydrochloride RS.

